The New York Times (8/12, Jacobs ) reports, “The journal Psychopharmacology has retracted three papers about MDMA-assisted therapy based on what the publication said was unethical conduct at one of the study sites where the research took place.” The conduct in question involved “a sexual relationship” between “an unlicensed Canadian therapist who took part in the trial” and “a participant after the conclusion of the trial’s dosing sessions.” Multiple authors “are affiliated with Lykos Therapeutics, the drug company whose application for MDMA-assisted therapy to treat post-traumatic stress disorder was rejected last week by the Food and Drug Administration.” While Lykos “said the research in the retracted papers was not part of its application to the F.D.A.,” on Sunday the company “said that it disagreed with Psychopharmacology’s decision and that it would file an official complaint with the Committee on Publication Ethics.”
Related Links:
— “The New York Times (requires login and subscription)